Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Accelerate Diagnostics stock

Learn how to easily invest in Accelerate Diagnostics stock.

Accelerate Diagnostics Inc is a medical devices business based in the US. Accelerate Diagnostics shares (AXDX) are listed on the NASDAQ and all prices are listed in US Dollars. Accelerate Diagnostics employs 220 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Accelerate Diagnostics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AXDX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Accelerate Diagnostics stock price (NASDAQ: AXDX)

Use our graph to track the performance of AXDX stocks over time.

Accelerate Diagnostics shares at a glance

Information last updated 2022-07-01.
Latest market close$1.04
52-week range$0.50 - $8.05
50-day moving average $0.81
200-day moving average $3.28
Wall St. target price$1.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.06

Buy Accelerate Diagnostics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
Stocks, ETFs, Cryptocurrency
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Axos Bank Self Directed Investing
when you open an account and deposit at least $1500.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Accelerate Diagnostics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Accelerate Diagnostics price performance over time

Historical closes compared with the close of $1.04 from 2022-07-01

1 week (2022-06-24) -23.53%
1 month (2022-06-03) 44.44%
3 months (2022-03-30) -25.71%
6 months (2022-01-03) -79.81%
1 year (2021-07-02) -86.92%
2 years (2020-07-02) -93.44%
3 years (2019-07-03) 23.92
5 years (2017-07-03) 27.6

Accelerate Diagnostics financials

Revenue TTM $12.2 million
Gross profit TTM $-381,000
Return on assets TTM -51.7%
Return on equity TTM 0%
Profit margin 0%
Book value $0.19
Market capitalisation $82.6 million

TTM: trailing 12 months

Accelerate Diagnostics share dividends

We're not expecting Accelerate Diagnostics to pay a dividend over the next 12 months.

Have Accelerate Diagnostics's shares ever split?

Accelerate Diagnostics's shares were split on a 1231:1230 basis on 7 July 2013. So if you had owned 1230 shares the day before before the split, the next day you'd have owned 1231 shares. This wouldn't directly have changed the overall worth of your Accelerate Diagnostics shares – just the quantity. However, indirectly, the new 0.1% lower share price could have impacted the market appetite for Accelerate Diagnostics shares which in turn could have impacted Accelerate Diagnostics's share price.

Accelerate Diagnostics share price volatility

Over the last 12 months, Accelerate Diagnostics's shares have ranged in value from as little as $0.5 up to $8.05. A popular way to gauge a stock's volatility is its "beta".

AXDX.US volatility(beta: 1.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accelerate Diagnostics's is 1.9211. This would suggest that Accelerate Diagnostics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Accelerate Diagnostics overview

Accelerate Diagnostics, Inc. , an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc.

Frequently asked questions

What percentage of Accelerate Diagnostics is owned by insiders or institutions?
Currently 35.691% of Accelerate Diagnostics shares are held by insiders and 29.535% by institutions.
How many people work for Accelerate Diagnostics?
Latest data suggests 220 work at Accelerate Diagnostics.
When does the fiscal year end for Accelerate Diagnostics?
Accelerate Diagnostics's fiscal year ends in December.
Where is Accelerate Diagnostics based?
Accelerate Diagnostics's address is: 3950 South Country Club Road, Tucson, AZ, United States, 85714
What is Accelerate Diagnostics's ISIN number?
Accelerate Diagnostics's international securities identification number is: US00430H1023
What is Accelerate Diagnostics's CUSIP number?
Accelerate Diagnostics's Committee on Uniform Securities Identification Procedures number is: 004304200

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site